Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
National Molecular Genetics Centre of Cancer Research, |
RCV000515491 | SCV000611550 | pathogenic | Peutz-Jeghers syndrome | 2017-08-07 | criteria provided, single submitter | clinical testing | Emory Genetics Laboratory Classification Definitions Pathogenic: a. Variants predicted to result in the loss of protein function in a gene for which this is a known mechanism of disease (may or may not have been previously reported in patients with disease) 1. frameshift (an insertion or deletion that is not a multiple of 3 nucleotides). |
Invitae | RCV000515491 | SCV000953376 | pathogenic | Peutz-Jeghers syndrome | 2018-12-17 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with STK11-related conditions. ClinVar contains an entry for this variant (Variation ID: 446257). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in STK11 are known to be pathogenic (PMID: 15188174, 16287113). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Val243Serfs*44) in the STK11 gene. It is expected to result in an absent or disrupted protein product. |
Genome- |
RCV000515491 | SCV002057376 | pathogenic | Peutz-Jeghers syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing |